Based on route of administration, the market is categorized into parenteral and oral, where parenteral formulations dominated with a 63.2% share
Retatrutide is a triple-receptor agonist (GLP-1, GIP, and Glucagon) that suppresses appetite, slows gastric emptying, and ramps up energy expenditure
Hepatic fat reduction is particularly notable for MASH research
"In addition," Dr
There are, however, multiple instances of federal statute requiring a uniform pharmacy program benefit across all TRICARE categories -- instances which appear to run counter to the recent GLP-1 ruling
CVS Caremark added that it will provide advance communication and support to customers, consultants, providers, and members to help facilitate the transition